Research and new methods

Preventing GVHD: calming donor cells

Graft-versus-host disease (GVHD) is when donor immune cells attack the patient's tissues. Prevention starts before the transplant and continues for months.

Last updated: ~1 min read
Two white tablets resting on an open hand
Figure 1.Preventive medicines

01Short answer

GVHD can affect the skin, liver, gut, mouth, eyes and lungs. Prevention uses medicines that suppress the immune system, cyclophosphamide after the transplant and antibodies against T cells. The challenge is balance: donor cells also act against the leukaemia (the graft-versus-leukaemia effect), so too much suppression may raise the relapse risk. New medicines and methods are being studied.

02Simple explanation

Donor cells may attack.

Prevention lasts months.

Balance matters.

Report changes.

03Scientific explanation

NCI: GVHD is a condition in which a donor's cells attack the recipient's normal tissue.

NCI: new treatments are tested step by step, from the laboratory to clinical trials; only those proven safe and beneficial become standard care.

04What happens in the body?

Signs

Rash, diarrhoea, jaundice, dry eyes and mouth, breathlessness.

A protective veil
Figure 2.A protective veil — Preventing GVHD: calming donor cells

Medicines

Only the team changes the schedule or stops them.

Balance
Figure 3.Balance — Preventing GVHD: calming donor cells

How to read the news

Research news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.

Talk to your doctor

Show your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

05From research news to a conversation: four steps

Read, check, ask, decide together.

Read — From a trusted source.1ReadFrom a trusted source.
Check — Phase, participants, result.2CheckPhase, participants, result.
Ask — Show your doctor.3AskShow your doctor.
Decide — Together, without rushing.4DecideTogether, without rushing.
SourceA trusted site.
DoctorA personal explanation.
SafetyNot changing treatment yourself.

06Key points at a glance

TopicIn brief
SignsRash, diarrhoea, jaundice, dry eyes and mouth, breathlessness.
MedicinesOnly the team changes the schedule or stops them.
How to read the newsResearch news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.
Talk to your doctorShow your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

07Key terms

GVHD
Graft-versus-host disease.
Immunosuppression
Weakening the immune system.
Clinical trial
Testing a new treatment with volunteers.
Evidence
A result confirmed by reliable research.

08Key points

  • Learn.
  • Ask your doctor.
  • Write it down.
  • Check the source.
  • Talk to your doctor.

09Frequently asked questions

Can I stop the medicine if I feel well?

No, only after agreeing with the team.

Does everyone get GVHD?

No, but there is a risk and it is monitored.

Is this advance right for me?

Only your treating doctor can say, based on your diagnosis, stage and condition.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

  1. Can I stop the medicine if I feel well?

  2. Does everyone get GVHD?

  3. Is this advance right for me?

My questions

12Sources

  1. National Cancer Institute. NCI Dictionary of Cancer Terms: graft-versus-host disease
  2. National Cancer Institute. Stem Cell and Bone Marrow Transplants for Cancer
  3. National Cancer Institute. What Are Clinical Trials?
  4. National Cancer Institute. Phases of Clinical Trials
  5. National Cancer Institute. Using Trusted Resources
  6. National Cancer Institute (NCI). Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®) — Patient Version
  7. National Cancer Institute (NCI). NCI Dictionary of Cancer Terms: minimal residual disease
  8. National Cancer Institute (NCI). The Genetics of Cancer
  9. National Cancer Institute (NCI). Biomarker Testing for Cancer Treatment
  10. National Cancer Institute (NCI). Targeted Therapy to Treat Cancer
Medical disclaimerThis information is for educational purposes only and does not replace medical advice.
Last updated: ← Back to the list